Margin(s) involved by invasive carcinoma in Breast tumor   44676-5

LOINC Code


LOINC code44676-5
nameMargin(s) involved by invasive carcinoma in Breast tumor
statusACTIVE

Fully-Specified Name

componentMargin(s) involved by invasive carcinoma
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemBreast tumor
scaleNom  =  Nominal:  Nominal or categorical responses that do not have a natural ordering. (e.g., names of bacteria, reported as answers, categories of appearance that do not have a natural ordering, such as, yellow, clear, bloody.
method

Additional Names

short nameMargin(s) involved by IC BT

Basic Attributes

classPATH.HISTO
type1  Laboratory
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

85904-1Cancer pathology panel - Breast cancer specimen by CAP cancer protocols

History/Usage

first released
last updated2.61
last change typeMAJ  - change to name field other than Component;
change reasonRemoved copyright and Method of "CAP cancer protocols" because this is not a CAP-specific concept. Added an example answer list.

Related Names

Brst
BT
Cancer
Finding
Findings
Margin(s) involved by IC
Nominal
PATH.HISTO
PATHOLOGY
Point in time
Random
S prime
tumors
tumour
tumours

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.